These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33737009)

  • 1. Inhibition of cyclooxygenase by blocking the reducing cosubstrate at the peroxidase site: Discovery of galangin as a novel cyclooxygenase inhibitor.
    Bai HW; Yang C; Wang P; Rao S; Zhu BT
    Eur J Pharmacol; 2021 May; 899():174036. PubMed ID: 33737009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of the Production of Prostaglandin E₂ by Ethyl Gallate, a Natural Phenolic Compound Richly Contained in Longan.
    Wang HR; Sui HC; Ding YY; Zhu BT
    Biomolecules; 2018 Sep; 8(3):. PubMed ID: 30200641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for certain naturally occurring bioflavonoids to function as reducing co-substrates of cyclooxygenase I and II.
    Wang P; Bai HW; Zhu BT
    PLoS One; 2010 Aug; 5(8):e12316. PubMed ID: 20808785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of reactivation of the peroxidase catalytic activity of human cyclooxygenases by reducing cosubstrate quercetin.
    Yang C; Li P; Wang P; Zhu BT
    J Mol Graph Model; 2021 Sep; 107():107941. PubMed ID: 34091174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazole derivatives as inhibitors of cyclooxygenases in vitro and in vivo.
    El-Achkar GA; Jouni M; Mrad MF; Hirz T; El Hachem N; Khalaf A; Hammoud S; Fayyad-Kazan H; Eid AA; Badran B; Merhi RA; Hachem A; Hamade E; Habib A
    Eur J Pharmacol; 2015 Mar; 750():66-73. PubMed ID: 25617797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzimidazole scaffold based hybrid molecules for various inflammatory targets: Synthesis and evaluation.
    Kaur G; Silakari O
    Bioorg Chem; 2018 Oct; 80():24-35. PubMed ID: 29864685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Docking of Bioactive Compounds Against BRCA and COX Proteins.
    Prog Drug Res; 2016; 71():181-3. PubMed ID: 26939289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoxazole-Based-Scaffold Inhibitors Targeting Cyclooxygenases (COXs).
    Perrone MG; Vitale P; Panella A; Ferorelli S; Contino M; Lavecchia A; Scilimati A
    ChemMedChem; 2016 Jun; 11(11):1172-87. PubMed ID: 27136372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1.
    Rimon G; Sidhu RS; Lauver DA; Lee JY; Sharma NP; Yuan C; Frieler RA; Trievel RC; Lucchesi BR; Smith WL
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):28-33. PubMed ID: 19955429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indole based cyclooxygenase inhibitors: synthesis, biological evaluation, docking and NMR screening.
    Estevão MS; Carvalho LC; Freitas M; Gomes A; Viegas A; Manso J; Erhardt S; Fernandes E; Cabrita EJ; Marques MM
    Eur J Med Chem; 2012 Aug; 54():823-33. PubMed ID: 22796043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Mechanisms in the Selectivity of Nonsteroidal Anti-Inflammatory Drugs.
    Shamsudin Y; Gutiérrez-de-Terán H; Åqvist J
    Biochemistry; 2018 Feb; 57(7):1236-1248. PubMed ID: 29345921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential modulation of cyclooxygenase-mediated prostaglandin production by the putative cancer chemopreventive flavonoids tricin, apigenin and quercetin.
    Al-Fayez M; Cai H; Tunstall R; Steward WP; Gescher AJ
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):816-25. PubMed ID: 16552572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer aided drug design approaches to develop cyclooxygenase based novel anti-inflammatory and anti-cancer drugs.
    Reddy RN; Mutyala R; Aparoy P; Reddanna P; Reddy MR
    Curr Pharm Des; 2007; 13(34):3505-17. PubMed ID: 18220787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel 1,2,4-triazine-quinoline hybrids: The privileged scaffolds as potent multi-target inhibitors of LPS-induced inflammatory response via dual COX-2 and 15-LOX inhibition.
    Ghanim AM; Rezq S; Ibrahim TS; Romero DG; Kothayer H
    Eur J Med Chem; 2021 Jul; 219():113457. PubMed ID: 33892270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, molecular docking, and biological evaluation of some novel hydrazones and pyrazole derivatives as anti-inflammatory agents.
    Mohammed KO; Nissan YM
    Chem Biol Drug Des; 2014 Oct; 84(4):473-88. PubMed ID: 24720475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, in vitro and in vivo biological evaluation, COX-1/2 inhibition and molecular docking study of indole-N-acylhydrazone derivatives.
    Moraes ADTO; Miranda MDS; Jacob ÍTT; Amorim CADC; Moura RO; Silva SÂSD; Soares MBP; Almeida SMV; Souza TRCL; Oliveira JF; Silva TGD; Melo CML; Moreira DRM; Lima MDCA
    Bioorg Med Chem; 2018 Nov; 26(20):5388-5396. PubMed ID: 30293795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, anti-inflammatory activity and COX-1/COX-2 inhibition of novel substituted cyclic imides. Part 1: Molecular docking study.
    Abdel-Aziz AA; ElTahir KE; Asiri YA
    Eur J Med Chem; 2011 May; 46(5):1648-55. PubMed ID: 21388719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of new nicotinate derivatives as potential anti-inflammatory agents targeting COX-2 enzyme.
    El-Dash Y; Khalil NA; Ahmed EM; Hassan MSA
    Bioorg Chem; 2021 Feb; 107():104610. PubMed ID: 33454504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4(3H)-quinazolinones.
    Abdel-Aziz AA; Abou-Zeid LA; ElTahir KEH; Ayyad RR; El-Sayed MA; El-Azab AS
    Eur J Med Chem; 2016 Oct; 121():410-421. PubMed ID: 27318118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavonoids inhibit COX-1 and COX-2 enzymes and cytokine/chemokine production in human whole blood.
    Ribeiro D; Freitas M; Tomé SM; Silva AM; Laufer S; Lima JL; Fernandes E
    Inflammation; 2015 Apr; 38(2):858-70. PubMed ID: 25139581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.